Back
Essilorluxottica Vs. Innate Pharma SA Industry Stock Comparison
Buy
87
ESLOY
Essilorluxottica
Last Price:
$153.86
Seasonality Move:
5.92%
Buy
60
IPHA
Innate Pharma SA
Last Price:
$2.25
Seasonality Move:
-9.46%
Buy
87
Essilorluxottica (ESLOY)
is a Buy
Is Essilorluxottica a Buy, Sell or Hold?
-
The current Essilorluxottica [ESLOY] share price is $153.86. The Score for ESLOY is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
ESLOY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
60
Innate Pharma SA (IPHA)
is a Buy
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.20. The Score for IPHA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
IPHA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ESLOY Stock Price Chart
What is Essilorluxottica's stock price today?
-
The Essilorluxottica share price today is $153.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESLOY is experiencing buying pressure, which is a positive indicator for future bullish movement.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ESLOY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.03 | Buy |
Relative Strength Index (14 RSI): | 81.93 | Buy |
Chaikin Money Flow: | 20139 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (129.93 - 148.27) | Buy |
Bollinger Bands (100): | (114.82 - 134.32) | Buy |
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 62.08 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ESLOY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 149.77 | Buy |
20-day SMA: | 142.2 | Buy |
50-day SMA: | 129.94 | Buy |
200-day SMA: | 118.52 | Buy |
8-day EMA: | 150.09 | Buy |
20-day EMA: | 143 | Buy |
50-day EMA: | 133.75 | Buy |
200-day EMA: | 120.18 | Buy |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.01 | Buy |
20-day SMA: | 1.89 | Buy |
50-day SMA: | 1.91 | Buy |
200-day SMA: | 2.11 | Buy |
8-day EMA: | 2.05 | Buy |
20-day EMA: | 1.95 | Buy |
50-day EMA: | 1.9 | Buy |
200-day EMA: | 2.08 | Buy |
Essilorluxottica Earnings Growth & ESLOY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Essilorluxottica Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innate Pharma SA Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |